FDA-cleared profile

cvi42 Auto Imaging Software Application

Circle Cardiovascular Imaging Inc · CT/CTA; MRI · FDA-cleared (510(k))

Authorized purpose: Viewing, post-processing, qualitative and quantitative evaluation, cardiac measurements, calcium scoring, and evaluation of physician-identified vascular lesions in cardiovascular MR/CT images.

Clinical role
Post-processing software for viewing and evaluating cardiovascular MR and CT images; machine learning aids semi-automatic contouring of regions of interest, and tools assist physicians with cardiac measurements, calcium scoring, and confirming physician-identified vessel lesions.
Images and patients
CT/CTA; MRI · Heart and adjacent cardiovascular vessels
Key limitation
Keep in mind: Only cardiac MR/CT images are in scope; semi-automated algorithms target adults; the 3D heart view is qualitative only; additional exact FDA limitations are unknown.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Viewing, post-processing, qualitative and quantitative evaluation, cardiac measurements, calcium scoring, and evaluation of physician-identified vascular lesions in cardiovascular MR/CT images.
  • Which images or clinical context are in scope?Modality: CT/CTA; MRI Anatomy or clinical context: Heart and adjacent cardiovascular vessels Input: DICOM cardiac MR and CT images; semi-automated machine-learning workflows are intended for adults.
  • Who uses it?Intended users: Qualified medical professionals experienced with cardiovascular MR/CT images.
  • What does the software produce?Output: Four-chamber contouring, coronary calcium scoring, coronary centerlines and stenosis assessment, measurements, reports, and qualitative 3D heart views.
  • What is its most important limitation?Key limitation: Only cardiac MR/CT images are in scope; semi-automated algorithms target adults; the 3D heart view is qualitative only; additional exact FDA limitations are unknown.

Clinical takeaway. Clinical role: Viewing, post-processing, qualitative and quantitative evaluation, cardiac measurements, calcium scoring, and evaluation of physician-identified vascular lesions in cardiovascular MR/CT images.

Evidence takeaway. Evidence from the reviewed source record: FDA summary reports 235 anonymized validation images independent from training, with at least 50% from a US population; reported ranges were 97-100% classification, 86-99% calcium classification, 82-94% coronary-centerline performance, and 98-100% mask performance.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Viewing, post-processing, qualitative and quantitative evaluation, cardiac measurements, calcium scoring, and evaluation of physician-identified vascular lesions in cardiovascular MR/CT images.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled in this remediation finding.

Workflow role
Post-processing software for viewing and evaluating cardiovascular MR and CT images; machine learning aids semi-automatic contouring of regions of interest, and tools assist physicians with cardiac measurements, calcium scoring, and confirming physician-identified vessel lesions.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "cvi42 Auto is intended to be used for viewing, post-processing, qualitative and quantitative evaluation of cardiovascular magnetic resonance (MR) and computed tomography (CT) images" … "cvi42 Auto uses machine learning techniques to aid in semi-automatic contouring of regions of interest of cardiac magnetic resonance (MR) or computed tomography (CT) images as follows:". Read from the exact FDA decision document on 2026-11-14.

Required input
DICOM cardiac MR and CT images; semi-automated machine-learning workflows are intended for adults.
  • Exact FDA submission
  • Checked 2026-09-19

FDA indications and device description.

Output and clinician action
Four-chamber contouring, coronary calcium scoring, coronary centerlines and stenosis assessment, measurements, reports, and qualitative 3D heart views.
  • Exact FDA submission
  • Checked 2026-09-19

FDA device description and feature comparison; 3D view has no quantitative assessment.

Care setting
Adult
  • Exact FDA submission
  • Checked 2026-09-01

Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.

Intended users
Qualified medical professionals experienced with cardiovascular MR/CT images.
  • Exact FDA submission
  • Checked 2026-09-19

FDA indications statement.

Limitations
Only cardiac MR/CT images are in scope; semi-automated algorithms target adults; the 3D heart view is qualitative only; additional exact FDA limitations are unknown.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA limitation boundary.

Evidence summary
FDA summary reports 235 anonymized validation images independent from training, with at least 50% from a US population; reported ranges were 97-100% classification, 86-99% calcium classification, 82-94% coronary-centerline performance, and 98-100% mask performance.
  • Exact FDA submission
  • Checked 2026-09-19

Submission-reported validation metrics; not independent clinical-outcomes evidence.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA summary reports 235 anonymized validation images independent from training, with at least 50% from a US population; reported ranges were 97-100% classification, 86-99% calcium classification, 82-94% coronary-centerline performance, and 98-100% mask performance.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Submission-reported validation metrics; not independent clinical-outcomes evidence.

Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

cvi42 Auto Imaging Software Application regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationAdult
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K213998
  • Samplen=235
  • IndependenceIndependence not established

K213998

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K213998. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: DICOM cardiac MR and CT images; semi-automated machine-learning workflows are intended for adults.

    Scope: Exact FDA submission. FDA indications and device description.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K213998: cvi42 Auto Imaging Software Application

  2. Routing

    Source context, not route validation: The exact-submission ACR model card explicitly references DICOM in the described input, output, or workflow; exact interfaces, versions, and local compatibility require confirmation.

    Scope: Exact FDA submission. Interoperability terms explicitly reported in the exact-submission ACR model card; interface versions and local compatibility still require confirmation.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-01 · cvi42 Auto Imaging Software Application model card (K213998)

  3. AI processing

    Source context, not route validation: The exact FDA package describes cvi42 Auto as workstation software for macOS or Microsoft Windows that can be integrated into a hospital, private practice environment, or medical research institution. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "The device can be integrated into a hospital, private practice environment, or medical research institution" … "Workstation operating macOS, macOS, macOS, macOS, system Microsoft Windows". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K213998: cvi42 Auto Imaging Software Application

  4. Returned objects

    Source context, not route validation: Four-chamber contouring, coronary calcium scoring, coronary centerlines and stenosis assessment, measurements, reports, and qualitative 3D heart views.

    Scope: Exact FDA submission. FDA device description and feature comparison; 3D view has no quantitative assessment.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K213998: cvi42 Auto Imaging Software Application

  5. Viewer/worklist/report

    Unresolved route: Four-chamber contouring, coronary calcium scoring, coronary centerlines and stenosis assessment, measurements, reports, and qualitative 3D heart views.

    Scope: Exact FDA submission. FDA device description and feature comparison; 3D view has no quantitative assessment.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K213998: cvi42 Auto Imaging Software Application

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes cvi42 Auto as workstation software for macOS or Microsoft Windows that can be integrated into a hospital, private practice environment, or medical research institution. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The device can be integrated into a hospital, private practice environment, or medical research institution" … "Workstation operating macOS, macOS, macOS, macOS, system Microsoft Windows". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The exact-submission ACR model card explicitly references DICOM in the described input, output, or workflow; exact interfaces, versions, and local compatibility require confirmation.
  • Exact FDA submission
  • Checked 2026-09-01

Interoperability terms explicitly reported in the exact-submission ACR model card; interface versions and local compatibility still require confirmation.

Security
Circle Cardiovascular Imaging's cvi42 page (dated 2026-05-05) states that cvi42 processes imaging data entirely within the customer's environment (hospital workstation or customer-managed server) with no data transmitted outside the institution; that the AI models are locked, frozen and encrypted when integrated into cvi42 and do not continue to learn once deployed; and that the AI does not learn from or store customer-site patient data. Vendor statement; no certification or test report was read.
  • Product family
  • Checked 2026-10-26

Vendor statement, not an attestation. The page is on circlecvi.com and describes cvi42 without naming a version, so it is family-level context.

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

Supported acquisition environment

Scanner manufacturers: All

exact submission · checked 2026-09-01

Confirm currently supported software versions, protocols, and site-specific acquisition configurations.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for cvi42 Auto Imaging Software Application; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K213998
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA; MRI
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

FDA MR and CT imaging modalities normalized to the controlled combined catalog enum.

Anatomy
Heart and adjacent cardiovascular vessels
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

FDA cardiovascular, cardiac, and adjacent-vessel scope.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2022-07-28
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K213998 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-09 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K213998: cvi42 Auto Imaging Software Application

    U.S. Food and Drug Administration - Published 2022-07-28 - Accessed 2026-09-09

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, purpose, intendedUsers, input, output, limitations, evidenceSummary, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. cvi42 Auto Imaging Software Application model card (K213998)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, limitations, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K213998

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

  8. Circle Cardiovascular Imaging: How AI Works in cvi42 - Secure, Smart, and Fully Local

    Circle Cardiovascular Imaging - Published 2026-05-05 - Accessed 2026-10-26

    Scope: security

Research history

  1. K213998 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K242781

cvi42 Software Application

Circle Cardiovascular Imaging Inc.

Authorized purpose: View, post-process, and qualitatively and quantitatively evaluate cardiovascular MR and CT images in DICOM format to obtain diagnostic information as part of a comprehensive diagnostic decision-making process.

Modality
CT/CTA; MRI
Anatomy
Cardiovascular system; heart, coronary and adjacent vessels, and cardiac valves
Decision
2024-10-15
FDA-cleared K192437

Arterys MICA

Arterys Inc.

Authorized purpose: Support-tool image processing for quantitative cardiovascular assessment and oncologic lesion evaluation, quantification, follow-up, and documentation to aid trained healthcare professionals in diagnosis; the software does not directly generate a diagnosis or potential findings.

Modality
CT/CTA; MRI
Anatomy
Heart and major vessels for Cardio AI; oncology lesion anatomy is not further specified in the FDA statement.
Decision
2020-03-25
FDA-cleared K182034

Arterys MICA

Arterys Inc.

Authorized purpose: DICOM/non-DICOM image and data management with optional quantitative cardiac MR and oncology lesion evaluation, quantification, follow-up, and documentation support; the software does not directly generate a diagnosis or potential findings.

Modality
CT/CTA; MRI
Anatomy
Heart and major vessels for the optional Cardio AI module; lung and liver lesions or nodules for the optional Oncology AI module; the base viewer handles broader radiological image data.
Decision
2018-10-17
FDA-cleared K231683

inHEART Models

inHEART, SAS

Authorized purpose: Create, review, analyze, annotate, export, and use 3D cardiac models to support reading, reporting, and therapeutic-intervention planning.

Modality
CT/CTA; MRI
Anatomy
Cardiac structures, including the aorta, atria, ventricles, pulmonary artery trunk, and right atrium/inferior vena cava structures described in the FDA performance table
Decision
2024-02-29

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history